Literature DB >> 19039650

Expression of obestatin and ghrelin in papillary thyroid carcinoma.

Aziz Karaoglu1, Suleyman Aydin, Adile F Dagli, David E Cummings, Ibrahim H Ozercan, Halit Canatan, Yusuf Ozkan.   

Abstract

Ghrelin and obestatin are two peptide hormones with opposing roles in the control of appetite: orexigenic and anorexigenic, respectively. Loss of appetite is a common, serious complication of many forms of malignancy. The goals of this study were to investigate: (i) whether there are differences in ghrelin and obestatin peptide expression in thyroid tissues from a series of papillary carcinoma cases and normal controls, and (ii) whether there are correlations between tissue ghrelin and obestatin levels in series of papillary carcinoma cases and normal controls. Immunohistochemical analysis showed that in sections of benign human thyroid tissue, anti-ghrelin antibody reacted with intense staining in colloid-filled follicles. In benign thyroid tissues, colloids displayed plentiful dispersion in comparison with papillary microcarcinomas, whereas colloids in malignant thyroid tissues were uncommon. We found markedly lower tissue ghrelin levels in thyroid tissue of patients with papillary carcinomas, compared with normal thyroid tissues (P = 0.001). Immunohistochemical analysis also showed that obestatin in papillary carcinoma stained positively to various degrees. Obestatin tissue levels in papillary carcinomas tended to be slightly higher than those in normal thyroid tissue, but this was not statistically significant (P = 0.29). We also report that thyroid tissue of patients with Hashimoto's thyroiditis produced ghrelin and obestatin at similar levels as in normal thyroid tissue, even though colloid in Hashimoto's disease is scarce. We conclude that depressed expression of ghrelin, but not obestatin, is specific to papillary carcinoma, and this difference might constitute a diagnostic tool to differentiate papillary carcinoma from normal thyroid tissue. We currently do not know how these peptides are regulated and what factors are involved in papillary carcinoma, which inhibit the expression of ghrelin but not obestatin. This issue warrants further studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19039650     DOI: 10.1007/s11010-008-9969-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

Review 1.  Gastrointestinal regulation of food intake.

Authors:  David E Cummings; Joost Overduin
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Ghrelin: a novel peptide with therapeutic effect in certain cancers?

Authors:  Suleyman Aydin; Hikmet Geckil; Aziz Karaoglu; Emin Tamer Elkiran
Journal:  Med Hypotheses       Date:  2007-04-18       Impact factor: 1.538

3.  Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of salivary gland.

Authors:  S Aydin; I H Ozercan; F Dagli; S Aydin; O Dogru; S Celebi; O Akin; S P Guzel
Journal:  Biotech Histochem       Date:  2005 May-Aug       Impact factor: 1.718

Review 4.  Molecular classification and biomarker discovery in papillary thyroid carcinoma.

Authors:  Orla Sheils
Journal:  Expert Rev Mol Diagn       Date:  2005-11       Impact factor: 5.225

5.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

Review 6.  Ghrelin: structure and function.

Authors:  Masayasu Kojima; Kenji Kangawa
Journal:  Physiol Rev       Date:  2005-04       Impact factor: 37.312

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  [Ghrelin expression in the tissues of different thyroid diseases].

Authors:  Yu-fang Zhang; Hai-ning Wang; Tian-pei Hong
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2006-04-18

Review 9.  Ghrelin in neuroendocrine organs and tumours.

Authors:  Chrysanthia A Leontiou; Giulia Franchi; Márta Korbonits
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

10.  Influence of thyroid status and growth hormone deficiency on ghrelin.

Authors:  J E Caminos; L M Seoane; S A Tovar; F F Casanueva; C Dieguez
Journal:  Eur J Endocrinol       Date:  2002-07       Impact factor: 6.664

View more
  7 in total

1.  Ghrelin and obestatin expression in oral squamous cell carcinoma: an immunohistochemical and biochemical study.

Authors:  Manar M Alnema; Suleyman Aydin; Yusuf Ozkan; Adile F Dagli; Hanifi I Ozercan; Nezahat Yildirim; Ibrahim Sahin; Aziz Karaoglu; Nermin Kilic; Mustafa Yilmaz; Mehmet R Ozercan; Emir Donder
Journal:  Mol Cell Biochem       Date:  2010-01-03       Impact factor: 3.396

2.  Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels.

Authors:  Cristina Ciuoli; Lucia Brusco; Alexandra Theodoropoulou; Maria Grazia Castagna; Ornella Neri; Letizia Pasqui; Furio Pacini
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-16       Impact factor: 5.555

3.  A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance.

Authors:  Manuel D Gahete; José Córdoba-Chacón; Marta Hergueta-Redondo; Antonio J Martínez-Fuentes; Rhonda D Kineman; Gema Moreno-Bueno; Raúl M Luque; Justo P Castaño
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

4.  Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R.

Authors:  Geetali Pradhan; Chia-Shan Wu; Jong Han Lee; Preeti Kanikarla; Shaodong Guo; Vijay K Yechoor; Susan L Samson; Yuxiang Sun
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

5.  Circulating adipokines and metabolic setting in differentiated thyroid cancer.

Authors:  Chiara Mele; Maria Teresa Samà; Alessandro Angelo Bisoffi; Marina Caputo; Valentina Bullara; Stefania Mai; Gillian Elisabeth Walker; Flavia Prodam; Paolo Marzullo; Gianluca Aimaretti; Loredana Pagano
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

6.  The role of metabolic setting in predicting the risk of early tumour relapse of differentiated thyroid cancer (DTC).

Authors:  Chiara Mele; Marina Caputo; Maria Teresa Samà; Valentina Bullara; Maria Grazia Mauri; Flavia Prodam; Gianluca Aimaretti; Loredana Pagano; Paolo Marzullo
Journal:  Eur J Clin Nutr       Date:  2020-06-09       Impact factor: 4.016

Review 7.  Adipocytokines in thyroid dysfunction.

Authors:  Berna İmge Aydogan; Mustafa Sahin
Journal:  ISRN Inflamm       Date:  2013-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.